The broad scale effects of MYC overexpression on metabolic genes in MM and the fact that knockdown of these genes, or inhibition of these enzymes, are generally lethal suggests that MYC overexpression results in a metabolic Achilles’ heel that could be exploited therapeutically. The gene discussed is MYC; the disease is Miyoshi myopathy.